Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
Osteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies, namel...
Main Authors: | Yoshiyuki Suehara, Daisuke Kubota, Kazutaka Kikuta, Kazuo Kaneko, Akira Kawai, Tadashi Kondo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2012/425636 |
Similar Items
-
A proteomics approach for the development of sarcoma biomarkers
by: Tadashi Kondo, et al.
Published: (2014-09-01) -
miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
by: Daisuke Kubota, et al.
Published: (2016-01-01) -
Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.
by: Daisuke Kubota, et al.
Published: (2013-01-01) -
Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
by: Anita K. Luu, et al.
Published: (2021-10-01) -
Biomarker discovery in Alzheimer''s disease by proteomic approaches
by: Li-Jhen Chen, et al.
Published: (2009)